Monday, 19 October 202611:29 am ISTIndia edition

Just in

10:12 am‘How can public feel safe?’: Zeeshan Siddique claims ‘four threats in two months’ after Tiger Shroff incident
10:11 amFarmers plan sustained protest over voter rights, to coordinate with CJP: Vijoo Krishnan
10:10 amBike used for firing at Tiger Shroff recovered by police, two detained
10:06 amPolice raid ganja farm in Belagavi, arrest farmer
10:01 amKarnataka Chief Minister D.K. Shivakumar seeks Prime Minister Narendra Modi’s appointment to discuss sugarcane growers’ issues and drought
SponsoredPut your announcement in this ticker from ₹69/day
9:52 amRail passengers could face fine, jail time for loud calls, playing audio on speakers
9:43 amMinister Chennithala warns of crackdown on illegal spas, says legislation under consideration
9:38 amOne dead, several injured in clashes in Manipur's Thoubal district, prohibitory orders clamped
9:29 amAlbanian PM refuses to quit as violent protests enter sixth day
9:27 amTeen detained in Karnataka's Kalaburagi over suspected Lashkar-e-Taiba contacts
9:24 amCentre Advises Meta To Review Recommendation Systems To Prevent Public Disorder
9:24 amHow Keralam can overcome its legacy infrastructure deficit
9:16 amStock Market LIVE Updates, Sensex Today: Sensex, Nifty Trade Flat, Oil Retreats From 5-Month High
9:15 amTiger Shroff Attack Claim Draws Focus On Anil Pandit. Who Is He?
10:12 am‘How can public feel safe?’: Zeeshan Siddique claims ‘four threats in two months’ after Tiger Shroff incident
10:11 amFarmers plan sustained protest over voter rights, to coordinate with CJP: Vijoo Krishnan
10:10 amBike used for firing at Tiger Shroff recovered by police, two detained
10:06 amPolice raid ganja farm in Belagavi, arrest farmer
10:01 amKarnataka Chief Minister D.K. Shivakumar seeks Prime Minister Narendra Modi’s appointment to discuss sugarcane growers’ issues and drought
SponsoredPut your announcement in this ticker from ₹69/day
9:52 amRail passengers could face fine, jail time for loud calls, playing audio on speakers
9:43 amMinister Chennithala warns of crackdown on illegal spas, says legislation under consideration
9:38 amOne dead, several injured in clashes in Manipur's Thoubal district, prohibitory orders clamped
9:29 amAlbanian PM refuses to quit as violent protests enter sixth day
9:27 amTeen detained in Karnataka's Kalaburagi over suspected Lashkar-e-Taiba contacts
9:24 amCentre Advises Meta To Review Recommendation Systems To Prevent Public Disorder
9:24 amHow Keralam can overcome its legacy infrastructure deficit
9:16 amStock Market LIVE Updates, Sensex Today: Sensex, Nifty Trade Flat, Oil Retreats From 5-Month High
9:15 amTiger Shroff Attack Claim Draws Focus On Anil Pandit. Who Is He?

Health

Icotrokinra an oral IL-23 Receptor Blocker Shows Sustained Efficacy in Ulcerative Colitis: NEJM

Reported by Business Medical Dialogues 18 Oct 2026, 9:00 pm IST 1 min read

Image: Business Medical Dialogues. Rights remain with the publisher.

The phase IIb ANTHEM-UC trial found that icotrokinra (Icotyde), an oral peptide that blocks the interleukin-23 (IL-23) receptor, demonstrated sustained long-term efficacy in patients with moderately...

Read the full report on Business Medical Dialogues

Story file

Section: Health
First reported by: Business Medical Dialogues
Reporter: dr riya dave
Published: Sunday, 18 October 2026, 9:00 pm IST
Coverage: One outlet so far

How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.